{"id":342493,"date":"2025-08-20T18:21:07","date_gmt":"2025-08-20T18:21:07","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-biocryst-pharmaceuticals\/"},"modified":"2025-08-20T18:21:07","modified_gmt":"2025-08-20T18:21:07","slug":"how-to-buy-biocryst-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334063,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-342493","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals (BCRX) v\u1edbi gi\u00e1 hi\u1ec7n t\u1ea1i l\u00e0 $8,28. Kh\u00e1m ph\u00e1 c\u00e1c chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch, r\u1ee7i ro v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed5i m\u1edbi n\u00e0y trong n\u0103m 2025.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals (BCRX) v\u1edbi gi\u00e1 hi\u1ec7n t\u1ea1i l\u00e0 $8,28. Kh\u00e1m ph\u00e1 c\u00e1c chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch, r\u1ee7i ro v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed5i m\u1edbi n\u00e0y trong n\u0103m 2025."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111ang thay \u0111\u1ed5i c\u00e1ch \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh hi\u1ebfm g\u1eb7p? BioCryst Pharmaceuticals (BCRX) k\u1ebft h\u1ee3p \u0111\u1ed5i m\u1edbi khoa h\u1ecdc v\u1edbi th\u00e0nh c\u00f4ng th\u01b0\u01a1ng m\u1ea1i\u2014l\u00fd t\u01b0\u1edfng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u00ecm ki\u1ebfm t\u0103ng tr\u01b0\u1edfng trong l\u0129nh v\u1ef1c ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe. V\u1edbi thu\u1ed1c ch\u1ee7 l\u1ef1c ORLADEYO c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb ph\u00f9 m\u1ea1ch di truy\u1ec1n, c\u00f4ng ty n\u00e0y mang \u0111\u1ebfn nh\u1eefng c\u01a1 h\u1ed9i \u0111\u1ed9c \u0111\u00e1o. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 m\u1ecdi th\u1ee9 t\u1eeb hi\u1ec7u su\u1ea5t c\u1ed5 phi\u1ebfu hi\u1ec7n t\u1ea1i \u0111\u1ebfn c\u00e1c chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 th\u00f4ng minh.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111ang thay \u0111\u1ed5i c\u00e1ch \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh hi\u1ebfm g\u1eb7p? BioCryst Pharmaceuticals (BCRX) k\u1ebft h\u1ee3p \u0111\u1ed5i m\u1edbi khoa h\u1ecdc v\u1edbi th\u00e0nh c\u00f4ng th\u01b0\u01a1ng m\u1ea1i\u2014l\u00fd t\u01b0\u1edfng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u00ecm ki\u1ebfm t\u0103ng tr\u01b0\u1edfng trong l\u0129nh v\u1ef1c ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe. V\u1edbi thu\u1ed1c ch\u1ee7 l\u1ef1c ORLADEYO c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb ph\u00f9 m\u1ea1ch di truy\u1ec1n, c\u00f4ng ty n\u00e0y mang \u0111\u1ebfn nh\u1eefng c\u01a1 h\u1ed9i \u0111\u1ed9c \u0111\u00e1o. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 m\u1ecdi th\u1ee9 t\u1eeb hi\u1ec7u su\u1ea5t c\u1ed5 phi\u1ebfu hi\u1ec7n t\u1ea1i \u0111\u1ebfn c\u00e1c chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 th\u00f4ng minh."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu BioCryst: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 20 th\u00e1ng 8 n\u0103m 2025, BioCryst Pharmaceuticals (BCRX) giao d\u1ecbch \u1edf m\u1ee9c <strong>$8,28<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>ng\u00e0y 3 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng\u2014\u0111\u00f3 l\u00e0 khi BioCryst c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u00e1o c\u00e1o n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p> <h3>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu BCRX<\/h3> <table> <thead> <tr> <th>Ng\u00e0y<\/th> <th>S\u1ef1 ki\u1ec7n<\/th> <th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th> <th>Thay \u0110\u1ed5i Sau Tin<\/th> <\/tr> <\/thead> <tbody> <tr> <td>4 th\u00e1ng 8, 2025<\/td> <td>L\u1ee3i nhu\u1eadn qu\u00fd 2<\/td> <td>$8,14<\/td> <td>+1,7% (v\u01b0\u1ee3t d\u1ef1 b\u00e1o)<\/td> <\/tr> <tr> <td>5 th\u00e1ng 5, 2025<\/td> <td>L\u1ee3i nhu\u1eadn qu\u00fd 1<\/td> <td>$7,95<\/td> <td>+2,4% (h\u01b0\u1edbng d\u1eabn t\u00edch c\u1ef1c)<\/td> <\/tr> <tr> <td>10 th\u00e1ng 2, 2025<\/td> <td>K\u1ebft qu\u1ea3 h\u00e0ng n\u0103m<\/td> <td>$7,80<\/td> <td>+1,9% (t\u0103ng tr\u01b0\u1edfng doanh thu)<\/td> <\/tr> <tr> <td>4 th\u00e1ng 11, 2024<\/td> <td>L\u1ee3i nhu\u1eadn qu\u00fd 3<\/td> <td>$7,65<\/td> <td>-2,1% (kh\u00f4ng \u0111\u1ea1t m\u1ee5c ti\u00eau)<\/td> <\/tr> <tr> <td>5 th\u00e1ng 8, 2024<\/td> <td>L\u1ee3i nhu\u1eadn qu\u00fd 2<\/td> <td>$7,50<\/td> <td>+2,0% (ti\u1ebfn tri\u1ec3n pipeline)<\/td> <\/tr> <tr> <td>6 th\u00e1ng 5, 2024<\/td> <td>L\u1ee3i nhu\u1eadn qu\u00fd 1<\/td> <td>$7,35<\/td> <td>+2,0% (t\u0103ng tr\u01b0\u1edfng ORLADEYO)<\/td> <\/tr> <\/tbody> <\/table> <p><strong>Nh\u1eadn \u0111\u1ecbnh xu h\u01b0\u1edbng<\/strong>: C\u00e1c b\u1ea5t ng\u1edd t\u00edch c\u1ef1c v\u1ec1 l\u1ee3i nhu\u1eadn th\u01b0\u1eddng \u0111\u1ea9y gi\u00e1 t\u0103ng 2-3%, trong khi c\u00e1c k\u1ebft qu\u1ea3 kh\u00f4ng \u0111\u1ea1t g\u00e2y ra s\u1ee5t gi\u1ea3m t\u1ea1m th\u1eddi t\u01b0\u01a1ng t\u1ef1. C\u1ed5 phi\u1ebfu th\u1ec3 hi\u1ec7n s\u1ef1 b\u1ec1n b\u1ec9 v\u1edbi kh\u1ea3 n\u0103ng ph\u1ee5c h\u1ed3i nhanh nh\u1edd n\u1ec1n t\u1ea3ng v\u1eefng ch\u1eafc.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 - Th\u00e1ng 8 N\u0103m 2025)<\/h2> <p>C\u1ed5 phi\u1ebfu BCRX \u0111\u00e3 tr\u1ea3i qua m\u1ed9t <strong>chuy\u1ebfn t\u00e0u l\u01b0\u1ee3n si\u00eau t\u1ed1c<\/strong> v\u1edbi hi\u1ec7u su\u1ea5t t\u1ed5ng th\u1ec3 \u1ea5n t\u01b0\u1ee3ng:<\/p> <ul> <li><strong>Th\u00e1ng 2<\/strong>: $7,80 (h\u1ee3p nh\u1ea5t sau k\u1ef3 ngh\u1ec9 l\u1ec5)<\/li> <li><strong>Th\u00e1ng 3<\/strong>: $8,20 (\u0111\u00e0 b\u00e1n ORLADEYO)<\/li> <li><strong>Th\u00e1ng 4<\/strong>: $8,50 (n\u00e2ng h\u1ea1ng c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch)<\/li> <li><strong>Th\u00e1ng 5<\/strong>: $8,10 (bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng)<\/li> <li><strong>Th\u00e1ng 6<\/strong>: $8,40 (ti\u1ebfn tri\u1ec3n pipeline)<\/li> <li><strong>Th\u00e1ng 7<\/strong>: $8,60 (mong \u0111\u1ee3i l\u1ee3i nhu\u1eadn qu\u00fd 2)<\/li> <li><strong>Th\u00e1ng 8<\/strong>: $8,28 (h\u1ee3p nh\u1ea5t sau b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn)<\/li> <\/ul> <p><strong>T\u1ea1i sao l\u1ea1i bi\u1ebfn \u0111\u1ed9ng?<\/strong> C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u01b0\u1eddng dao \u0111\u1ed9ng theo tin t\u1ee9c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA v\u00e0 k\u1ebft qu\u1ea3 qu\u00fd. Ph\u1ea1m vi 52 tu\u1ea7n c\u1ee7a BCRX t\u1eeb $6,01 \u0111\u1ebfn $11,31 cho th\u1ea5y s\u1ef1 bi\u1ebfn \u0111\u1ed9ng v\u1ed1n c\u00f3 c\u1ee7a ng\u00e0nh.<\/p> <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <h3>Ng\u1eafn h\u1ea1n (2025)<\/h3> <p><strong>M\u1ee5c ti\u00eau<\/strong>: $16,70-$17,90 (+101-110% t\u0103ng)<br> <strong>K\u1ebft lu\u1eadn<\/strong>: <strong>MUA M\u1ea0NH<\/strong><br> C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o doanh thu ti\u1ebfp t\u1ee5c t\u0103ng tr\u01b0\u1edfng nh\u1edd m\u1edf r\u1ed9ng ORLADEYO v\u00e0 kh\u1ea3 n\u0103ng ph\u00ea duy\u1ec7t cho tr\u1ebb em.<\/p> <h3>Trung h\u1ea1n (2026)<\/h3> <p><strong>M\u1ee5c ti\u00eau<\/strong>: $20-25<br> Ti\u1ebfn tri\u1ec3n pipeline v\u00e0 kh\u1ea3 n\u0103ng ra m\u1eaft s\u1ea3n ph\u1ea9m m\u1edbi c\u00f3 th\u1ec3 th\u00fac \u0111\u1ea9y t\u0103ng gi\u00e1 th\u00eam.<\/p> <h3>D\u00e0i h\u1ea1n (2028)<\/h3> <p><strong>M\u1ee5c ti\u00eau<\/strong>: $30-35<br> Th\u1ed1ng l\u0129nh th\u1ecb tr\u01b0\u1eddng \u0111i\u1ec1u tr\u1ecb b\u1ec7nh hi\u1ebfm v\u00e0 m\u1edf r\u1ed9ng qu\u1ed1c t\u1ebf.<\/p> <h3>Tri\u1ec3n v\u1ecdng m\u1edf r\u1ed9ng (2030)<\/h3> <p><strong>M\u1ee5c ti\u00eau<\/strong>: $40-50<br> Ti\u1ec1m n\u0103ng tr\u1edf th\u00e0nh thu\u1ed1c blockbusters cho c\u00e1c \u1ee9ng vi\u00ean pipeline v\u00e0 t\u0103ng tr\u01b0\u1edfng doanh thu b\u1ec1n v\u1eefng.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i ro c\u1ea7n c\u00e2n nh\u1eafc<\/h3> <ul> <li><strong>Kh\u00f4ng ch\u1eafc ch\u1eafn v\u1ec1 quy \u0111\u1ecbnh FDA<\/strong>: Quy\u1ebft \u0111\u1ecbnh ti\u00eau c\u1ef1c v\u1ec1 m\u1edf r\u1ed9ng nh\u00e3n cho tr\u1ebb em s\u1ebd l\u00e0 b\u01b0\u1edbc l\u00f9i l\u1edbn<\/li> <li><strong>\u00c1p l\u1ef1c c\u1ea1nh tranh<\/strong>: Vi\u1ec7c ph\u00ea duy\u1ec7t Donidalorsen c\u00f3 th\u1ec3 \u0111e d\u1ecda th\u1ecb ph\u1ea7n ORLADEYO<\/li> <li><strong>M\u1ea5t doanh thu ch\u00e2u \u00c2u<\/strong>: S\u1eafp m\u1ea5t c\u00e1c d\u00f2ng doanh thu t\u1eeb ch\u00e2u \u00c2u<\/li> <li><strong>Ph\u1ee5 thu\u1ed9c v\u00e0o m\u1ed9t s\u1ea3n ph\u1ea9m duy nh\u1ea5t<\/strong>: Ph\u1ee5 thu\u1ed9c n\u1eb7ng v\u00e0o ORLADEYO (92% doanh thu)<\/li> <li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: C\u00e1c \u1ee9ng vi\u00ean pipeline nh\u01b0 BCX17725 c\u00f3 th\u1ec3 th\u1ea5t b\u1ea1i<\/li> <\/ul> <h3>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho n\u0103m 2025<\/h3> <ul> <li><strong>V\u01b0\u1ee3t l\u1ee3i nhu\u1eadn<\/strong>: Doanh thu qu\u00fd 2 \u0111\u1ea1t $163 tri\u1ec7u, v\u01b0\u1ee3t 9% d\u1ef1 b\u00e1o<\/li> <li><strong>\u0110\u1ed3ng thu\u1eadn nh\u00e0 ph\u00e2n t\u00edch<\/strong>: 95% \u0111\u00e1nh gi\u00e1 \"Mua\" ho\u1eb7c \"Mua M\u1ea1nh\"<\/li> <li><strong>T\u0103ng tr\u01b0\u1edfng doanh thu<\/strong>: T\u1ed1c \u0111\u1ed9 t\u0103ng tr\u01b0\u1edfng h\u00e0ng n\u0103m 49,4%<\/li> <li><strong>D\u00f2ng ti\u1ec1n d\u01b0\u01a1ng<\/strong>: D\u00f2ng ti\u1ec1n t\u1ef1 do $54 tri\u1ec7u t\u00e0i tr\u1ee3 R&D<\/li> <li><strong>Ti\u1ebfn tri\u1ec3n pipeline<\/strong>: BCX17725 ti\u1ebfn tri\u1ec3n cho h\u1ed9i ch\u1ee9ng Netherton<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: S\u1eed d\u1ee5ng ph\u01b0\u01a1ng ph\u00e1p trung b\u00ecnh gi\u00e1 theo \u0111\u00f4 la\u2014\u0111\u1ea7u t\u01b0 $100-$200 m\u1ed7i tu\u1ea7n \u0111\u1ec3 tr\u00e1nh sai l\u1ea7m v\u1ec1 th\u1eddi \u0111i\u1ec3m<\/li> <li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/strong>: Theo d\u00f5i l\u1ee3i nhu\u1eadn ng\u00e0y 3 th\u00e1ng 11; mua khi gi\u00e1 gi\u1ea3m 3-5%<\/li> <li><strong>\u0110a d\u1ea1ng h\u00f3a<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 5-7% danh m\u1ee5c v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li> <li><strong>Lu\u00f4n c\u1eadp nh\u1eadt<\/strong>: Theo d\u00f5i ch\u1eb7t ch\u1ebd c\u00e1c quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA v\u00e0 k\u1ebft qu\u1ea3 qu\u00fd<\/li> <\/ol> <p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: \"Giao d\u1ecbch BCRX gi\u1ed1ng nh\u01b0 d\u1eaft m\u00e8o \u0111i d\u1ea1o\u2014h\u00e0o h\u1ee9ng nh\u01b0ng kh\u00f3 \u0111o\u00e1n. H\u00e3y nh\u1edb, ngay c\u1ea3 nh\u1eefng c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc t\u1ed1t nh\u1ea5t c\u0169ng c\u1ea7n \u0111\u1ebfn ch\u00edn m\u1ea1ng \u0111\u1ec3 v\u01b0\u1ee3t qua c\u00e1c ph\u00ea duy\u1ec7t c\u1ee7a FDA!\"<\/p> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr> <th>B\u01b0\u1edbc<\/th> <th>H\u00e0nh \u0111\u1ed9ng<\/th> <th>T\u1ea1i sao quan tr\u1ecdng<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td> <td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng cung c\u1ea5p c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft tr\u00ean NASDAQ<\/td> <\/tr> <tr> <td>2<\/td> <td>M\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td> <td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n v\u1eeba ph\u1ea3i ($500-$1000)<\/td> <\/tr> <tr> <td>3<\/td> <td>Nghi\u00ean c\u1ee9u BCRX<\/td> <td>Hi\u1ec3u v\u1ec1 s\u1ea3n ph\u1ea9m v\u00e0 r\u1ee7i ro c\u1ee7a c\u00f4ng ty<\/td> <\/tr> <tr> <td>4<\/td> <td>\u0110\u1eb7t l\u1ec7nh mua<\/td> <td>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n quanh m\u1ee9c $8,00-$8,50<\/td> <\/tr> <tr> <td>5<\/td> <td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf<\/td> <td>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7 \u1edf m\u1ee9c 15-20% d\u01b0\u1edbi gi\u00e1 mua<\/td> <\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i sao Pocket Option ph\u00f9 h\u1ee3p v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p s\u1ef1 ti\u1ebfp c\u1eadn tuy\u1ec7t v\u1eddi:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u: $5<\/strong> \u2014 Th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li> <li><strong>X\u00e1c minh KYC trong 1 ph\u00fat<\/strong> \u2014 T\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch ngay l\u1eadp t\u1ee9c<\/li> <li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> \u2014 Bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed, th\u1ebb ng\u00e2n h\u00e0ng<\/li> <li><strong>T\u00e0i kho\u1ea3n demo v\u1edbi $50,000<\/strong> \u2014 Luy\u1ec7n t\u1eadp kh\u00f4ng r\u1ee7i ro tr\u01b0\u1edbc khi \u0111\u1ea7u t\u01b0 ti\u1ec1n th\u1eadt<\/li> <\/ul> <p>T\u00ednh n\u0103ng Giao d\u1ecbch Nhanh c\u1ee7a n\u1ec1n t\u1ea3ng cho ph\u00e9p b\u1ea1n d\u1ef1 \u0111o\u00e1n bi\u1ebfn \u0111\u1ed9ng gi\u00e1 BCRX m\u00e0 kh\u00f4ng c\u1ea7n s\u1edf h\u1eefu c\u1ed5 phi\u1ebfu th\u1ef1c\u2014l\u00fd t\u01b0\u1edfng \u0111\u1ec3 h\u1ecdc c\u00e1ch v\u1eadn h\u00e0nh th\u1ecb tr\u01b0\u1eddng.<\/p> <h2>\ud83c\udf0d BioCryst N\u0103m 2025: Ng\u01b0\u1eddi Ti\u00ean Phong Trong B\u1ec7nh Hi\u1ebfm<\/h2> <p>BioCryst Pharmaceuticals chi\u1ebfm l\u0129nh th\u1ecb tr\u01b0\u1eddng \u0111i\u1ec1u tr\u1ecb ph\u00f9 m\u1ea1ch di truy\u1ec1n v\u1edbi ORLADEYO, t\u1ea1o ra h\u01a1n $580 tri\u1ec7u m\u1ed7i n\u0103m. Ngo\u00e0i s\u1ea3n ph\u1ea9m ch\u1ee7 l\u1ef1c, h\u1ecd \u0111ang ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb h\u1ed9i ch\u1ee9ng Netherton v\u00e0 ph\u00f9 ho\u00e0ng \u0111i\u1ec3m do ti\u1ec3u \u0111\u01b0\u1eddng.<\/p> <p>C\u00f4ng ty duy tr\u00ec c\u00e1c quan h\u1ec7 \u0111\u1ed1i t\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u1edbi c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn v\u00e0 c\u01a1 quan ch\u00ednh ph\u1ee7 trong khi t\u1eadp trung v\u00e0o c\u00e1c li\u1ec7u ph\u00e1p \u0111\u01b0\u1eddng u\u1ed1ng gi\u00fap b\u1ec7nh nh\u00e2n ti\u1ec7n l\u1ee3i h\u01a1n so v\u1edbi thu\u1ed1c ti\u00eam truy\u1ec1n th\u1ed1ng.<\/p> <p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb<\/strong>: N\u0103m 2025, BioCryst tr\u1edf th\u00e0nh c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7u ti\u00ean s\u1eed d\u1ee5ng t\u1ed1i \u01b0u h\u00f3a th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng b\u1eb1ng AI, r\u00fat ng\u1eafn th\u1eddi gian ph\u00e1t tri\u1ec3n 30% trong khi v\u1eabn duy tr\u00ec c\u00e1c ti\u00eau chu\u1ea9n an to\u00e0n nghi\u00eam ng\u1eb7t.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu BioCryst: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 20 th\u00e1ng 8 n\u0103m 2025, BioCryst Pharmaceuticals (BCRX) giao d\u1ecbch \u1edf m\u1ee9c <strong>$8,28<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>ng\u00e0y 3 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng\u2014\u0111\u00f3 l\u00e0 khi BioCryst c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u00e1o c\u00e1o n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p>\n<h3>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu BCRX<\/h3>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>4 th\u00e1ng 8, 2025<\/td>\n<td>L\u1ee3i nhu\u1eadn qu\u00fd 2<\/td>\n<td>$8,14<\/td>\n<td>+1,7% (v\u01b0\u1ee3t d\u1ef1 b\u00e1o)<\/td>\n<\/tr>\n<tr>\n<td>5 th\u00e1ng 5, 2025<\/td>\n<td>L\u1ee3i nhu\u1eadn qu\u00fd 1<\/td>\n<td>$7,95<\/td>\n<td>+2,4% (h\u01b0\u1edbng d\u1eabn t\u00edch c\u1ef1c)<\/td>\n<\/tr>\n<tr>\n<td>10 th\u00e1ng 2, 2025<\/td>\n<td>K\u1ebft qu\u1ea3 h\u00e0ng n\u0103m<\/td>\n<td>$7,80<\/td>\n<td>+1,9% (t\u0103ng tr\u01b0\u1edfng doanh thu)<\/td>\n<\/tr>\n<tr>\n<td>4 th\u00e1ng 11, 2024<\/td>\n<td>L\u1ee3i nhu\u1eadn qu\u00fd 3<\/td>\n<td>$7,65<\/td>\n<td>-2,1% (kh\u00f4ng \u0111\u1ea1t m\u1ee5c ti\u00eau)<\/td>\n<\/tr>\n<tr>\n<td>5 th\u00e1ng 8, 2024<\/td>\n<td>L\u1ee3i nhu\u1eadn qu\u00fd 2<\/td>\n<td>$7,50<\/td>\n<td>+2,0% (ti\u1ebfn tri\u1ec3n pipeline)<\/td>\n<\/tr>\n<tr>\n<td>6 th\u00e1ng 5, 2024<\/td>\n<td>L\u1ee3i nhu\u1eadn qu\u00fd 1<\/td>\n<td>$7,35<\/td>\n<td>+2,0% (t\u0103ng tr\u01b0\u1edfng ORLADEYO)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Nh\u1eadn \u0111\u1ecbnh xu h\u01b0\u1edbng<\/strong>: C\u00e1c b\u1ea5t ng\u1edd t\u00edch c\u1ef1c v\u1ec1 l\u1ee3i nhu\u1eadn th\u01b0\u1eddng \u0111\u1ea9y gi\u00e1 t\u0103ng 2-3%, trong khi c\u00e1c k\u1ebft qu\u1ea3 kh\u00f4ng \u0111\u1ea1t g\u00e2y ra s\u1ee5t gi\u1ea3m t\u1ea1m th\u1eddi t\u01b0\u01a1ng t\u1ef1. C\u1ed5 phi\u1ebfu th\u1ec3 hi\u1ec7n s\u1ef1 b\u1ec1n b\u1ec9 v\u1edbi kh\u1ea3 n\u0103ng ph\u1ee5c h\u1ed3i nhanh nh\u1edd n\u1ec1n t\u1ea3ng v\u1eefng ch\u1eafc.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 &#8211; Th\u00e1ng 8 N\u0103m 2025)<\/h2>\n<p>C\u1ed5 phi\u1ebfu BCRX \u0111\u00e3 tr\u1ea3i qua m\u1ed9t <strong>chuy\u1ebfn t\u00e0u l\u01b0\u1ee3n si\u00eau t\u1ed1c<\/strong> v\u1edbi hi\u1ec7u su\u1ea5t t\u1ed5ng th\u1ec3 \u1ea5n t\u01b0\u1ee3ng:<\/p>\n<ul>\n<li><strong>Th\u00e1ng 2<\/strong>: $7,80 (h\u1ee3p nh\u1ea5t sau k\u1ef3 ngh\u1ec9 l\u1ec5)<\/li>\n<li><strong>Th\u00e1ng 3<\/strong>: $8,20 (\u0111\u00e0 b\u00e1n ORLADEYO)<\/li>\n<li><strong>Th\u00e1ng 4<\/strong>: $8,50 (n\u00e2ng h\u1ea1ng c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch)<\/li>\n<li><strong>Th\u00e1ng 5<\/strong>: $8,10 (bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng)<\/li>\n<li><strong>Th\u00e1ng 6<\/strong>: $8,40 (ti\u1ebfn tri\u1ec3n pipeline)<\/li>\n<li><strong>Th\u00e1ng 7<\/strong>: $8,60 (mong \u0111\u1ee3i l\u1ee3i nhu\u1eadn qu\u00fd 2)<\/li>\n<li><strong>Th\u00e1ng 8<\/strong>: $8,28 (h\u1ee3p nh\u1ea5t sau b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn)<\/li>\n<\/ul>\n<p><strong>T\u1ea1i sao l\u1ea1i bi\u1ebfn \u0111\u1ed9ng?<\/strong> C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u01b0\u1eddng dao \u0111\u1ed9ng theo tin t\u1ee9c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA v\u00e0 k\u1ebft qu\u1ea3 qu\u00fd. Ph\u1ea1m vi 52 tu\u1ea7n c\u1ee7a BCRX t\u1eeb $6,01 \u0111\u1ebfn $11,31 cho th\u1ea5y s\u1ef1 bi\u1ebfn \u0111\u1ed9ng v\u1ed1n c\u00f3 c\u1ee7a ng\u00e0nh.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<h3>Ng\u1eafn h\u1ea1n (2025)<\/h3>\n<p><strong>M\u1ee5c ti\u00eau<\/strong>: $16,70-$17,90 (+101-110% t\u0103ng)<br \/> <strong>K\u1ebft lu\u1eadn<\/strong>: <strong>MUA M\u1ea0NH<\/strong><br \/> C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o doanh thu ti\u1ebfp t\u1ee5c t\u0103ng tr\u01b0\u1edfng nh\u1edd m\u1edf r\u1ed9ng ORLADEYO v\u00e0 kh\u1ea3 n\u0103ng ph\u00ea duy\u1ec7t cho tr\u1ebb em.<\/p>\n<h3>Trung h\u1ea1n (2026)<\/h3>\n<p><strong>M\u1ee5c ti\u00eau<\/strong>: $20-25<br \/> Ti\u1ebfn tri\u1ec3n pipeline v\u00e0 kh\u1ea3 n\u0103ng ra m\u1eaft s\u1ea3n ph\u1ea9m m\u1edbi c\u00f3 th\u1ec3 th\u00fac \u0111\u1ea9y t\u0103ng gi\u00e1 th\u00eam.<\/p>\n<h3>D\u00e0i h\u1ea1n (2028)<\/h3>\n<p><strong>M\u1ee5c ti\u00eau<\/strong>: $30-35<br \/> Th\u1ed1ng l\u0129nh th\u1ecb tr\u01b0\u1eddng \u0111i\u1ec1u tr\u1ecb b\u1ec7nh hi\u1ebfm v\u00e0 m\u1edf r\u1ed9ng qu\u1ed1c t\u1ebf.<\/p>\n<h3>Tri\u1ec3n v\u1ecdng m\u1edf r\u1ed9ng (2030)<\/h3>\n<p><strong>M\u1ee5c ti\u00eau<\/strong>: $40-50<br \/> Ti\u1ec1m n\u0103ng tr\u1edf th\u00e0nh thu\u1ed1c blockbusters cho c\u00e1c \u1ee9ng vi\u00ean pipeline v\u00e0 t\u0103ng tr\u01b0\u1edfng doanh thu b\u1ec1n v\u1eefng.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i ro c\u1ea7n c\u00e2n nh\u1eafc<\/h3>\n<ul>\n<li><strong>Kh\u00f4ng ch\u1eafc ch\u1eafn v\u1ec1 quy \u0111\u1ecbnh FDA<\/strong>: Quy\u1ebft \u0111\u1ecbnh ti\u00eau c\u1ef1c v\u1ec1 m\u1edf r\u1ed9ng nh\u00e3n cho tr\u1ebb em s\u1ebd l\u00e0 b\u01b0\u1edbc l\u00f9i l\u1edbn<\/li>\n<li><strong>\u00c1p l\u1ef1c c\u1ea1nh tranh<\/strong>: Vi\u1ec7c ph\u00ea duy\u1ec7t Donidalorsen c\u00f3 th\u1ec3 \u0111e d\u1ecda th\u1ecb ph\u1ea7n ORLADEYO<\/li>\n<li><strong>M\u1ea5t doanh thu ch\u00e2u \u00c2u<\/strong>: S\u1eafp m\u1ea5t c\u00e1c d\u00f2ng doanh thu t\u1eeb ch\u00e2u \u00c2u<\/li>\n<li><strong>Ph\u1ee5 thu\u1ed9c v\u00e0o m\u1ed9t s\u1ea3n ph\u1ea9m duy nh\u1ea5t<\/strong>: Ph\u1ee5 thu\u1ed9c n\u1eb7ng v\u00e0o ORLADEYO (92% doanh thu)<\/li>\n<li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: C\u00e1c \u1ee9ng vi\u00ean pipeline nh\u01b0 BCX17725 c\u00f3 th\u1ec3 th\u1ea5t b\u1ea1i<\/li>\n<\/ul>\n<h3>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho n\u0103m 2025<\/h3>\n<ul>\n<li><strong>V\u01b0\u1ee3t l\u1ee3i nhu\u1eadn<\/strong>: Doanh thu qu\u00fd 2 \u0111\u1ea1t $163 tri\u1ec7u, v\u01b0\u1ee3t 9% d\u1ef1 b\u00e1o<\/li>\n<li><strong>\u0110\u1ed3ng thu\u1eadn nh\u00e0 ph\u00e2n t\u00edch<\/strong>: 95% \u0111\u00e1nh gi\u00e1 &#8220;Mua&#8221; ho\u1eb7c &#8220;Mua M\u1ea1nh&#8221;<\/li>\n<li><strong>T\u0103ng tr\u01b0\u1edfng doanh thu<\/strong>: T\u1ed1c \u0111\u1ed9 t\u0103ng tr\u01b0\u1edfng h\u00e0ng n\u0103m 49,4%<\/li>\n<li><strong>D\u00f2ng ti\u1ec1n d\u01b0\u01a1ng<\/strong>: D\u00f2ng ti\u1ec1n t\u1ef1 do $54 tri\u1ec7u t\u00e0i tr\u1ee3 R&#038;D<\/li>\n<li><strong>Ti\u1ebfn tri\u1ec3n pipeline<\/strong>: BCX17725 ti\u1ebfn tri\u1ec3n cho h\u1ed9i ch\u1ee9ng Netherton<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: S\u1eed d\u1ee5ng ph\u01b0\u01a1ng ph\u00e1p trung b\u00ecnh gi\u00e1 theo \u0111\u00f4 la\u2014\u0111\u1ea7u t\u01b0 $100-$200 m\u1ed7i tu\u1ea7n \u0111\u1ec3 tr\u00e1nh sai l\u1ea7m v\u1ec1 th\u1eddi \u0111i\u1ec3m<\/li>\n<li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/strong>: Theo d\u00f5i l\u1ee3i nhu\u1eadn ng\u00e0y 3 th\u00e1ng 11; mua khi gi\u00e1 gi\u1ea3m 3-5%<\/li>\n<li><strong>\u0110a d\u1ea1ng h\u00f3a<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 5-7% danh m\u1ee5c v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li>\n<li><strong>Lu\u00f4n c\u1eadp nh\u1eadt<\/strong>: Theo d\u00f5i ch\u1eb7t ch\u1ebd c\u00e1c quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA v\u00e0 k\u1ebft qu\u1ea3 qu\u00fd<\/li>\n<\/ol>\n<p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: &#8220;Giao d\u1ecbch BCRX gi\u1ed1ng nh\u01b0 d\u1eaft m\u00e8o \u0111i d\u1ea1o\u2014h\u00e0o h\u1ee9ng nh\u01b0ng kh\u00f3 \u0111o\u00e1n. H\u00e3y nh\u1edb, ngay c\u1ea3 nh\u1eefng c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc t\u1ed1t nh\u1ea5t c\u0169ng c\u1ea7n \u0111\u1ebfn ch\u00edn m\u1ea1ng \u0111\u1ec3 v\u01b0\u1ee3t qua c\u00e1c ph\u00ea duy\u1ec7t c\u1ee7a FDA!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0111\u1ed9ng<\/th>\n<th>T\u1ea1i sao quan tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng cung c\u1ea5p c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft tr\u00ean NASDAQ<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>M\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n v\u1eeba ph\u1ea3i ($500-$1000)<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Nghi\u00ean c\u1ee9u BCRX<\/td>\n<td>Hi\u1ec3u v\u1ec1 s\u1ea3n ph\u1ea9m v\u00e0 r\u1ee7i ro c\u1ee7a c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>\u0110\u1eb7t l\u1ec7nh mua<\/td>\n<td>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n quanh m\u1ee9c $8,00-$8,50<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf<\/td>\n<td>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7 \u1edf m\u1ee9c 15-20% d\u01b0\u1edbi gi\u00e1 mua<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i sao Pocket Option ph\u00f9 h\u1ee3p v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p s\u1ef1 ti\u1ebfp c\u1eadn tuy\u1ec7t v\u1eddi:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u: $5<\/strong> \u2014 Th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li>\n<li><strong>X\u00e1c minh KYC trong 1 ph\u00fat<\/strong> \u2014 T\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch ngay l\u1eadp t\u1ee9c<\/li>\n<li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> \u2014 Bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed, th\u1ebb ng\u00e2n h\u00e0ng<\/li>\n<li><strong>T\u00e0i kho\u1ea3n demo v\u1edbi $50,000<\/strong> \u2014 Luy\u1ec7n t\u1eadp kh\u00f4ng r\u1ee7i ro tr\u01b0\u1edbc khi \u0111\u1ea7u t\u01b0 ti\u1ec1n th\u1eadt<\/li>\n<\/ul>\n<p>T\u00ednh n\u0103ng Giao d\u1ecbch Nhanh c\u1ee7a n\u1ec1n t\u1ea3ng cho ph\u00e9p b\u1ea1n d\u1ef1 \u0111o\u00e1n bi\u1ebfn \u0111\u1ed9ng gi\u00e1 BCRX m\u00e0 kh\u00f4ng c\u1ea7n s\u1edf h\u1eefu c\u1ed5 phi\u1ebfu th\u1ef1c\u2014l\u00fd t\u01b0\u1edfng \u0111\u1ec3 h\u1ecdc c\u00e1ch v\u1eadn h\u00e0nh th\u1ecb tr\u01b0\u1eddng.<\/p>\n<h2>\ud83c\udf0d BioCryst N\u0103m 2025: Ng\u01b0\u1eddi Ti\u00ean Phong Trong B\u1ec7nh Hi\u1ebfm<\/h2>\n<p>BioCryst Pharmaceuticals chi\u1ebfm l\u0129nh th\u1ecb tr\u01b0\u1eddng \u0111i\u1ec1u tr\u1ecb ph\u00f9 m\u1ea1ch di truy\u1ec1n v\u1edbi ORLADEYO, t\u1ea1o ra h\u01a1n $580 tri\u1ec7u m\u1ed7i n\u0103m. Ngo\u00e0i s\u1ea3n ph\u1ea9m ch\u1ee7 l\u1ef1c, h\u1ecd \u0111ang ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb h\u1ed9i ch\u1ee9ng Netherton v\u00e0 ph\u00f9 ho\u00e0ng \u0111i\u1ec3m do ti\u1ec3u \u0111\u01b0\u1eddng.<\/p>\n<p>C\u00f4ng ty duy tr\u00ec c\u00e1c quan h\u1ec7 \u0111\u1ed1i t\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u1edbi c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn v\u00e0 c\u01a1 quan ch\u00ednh ph\u1ee7 trong khi t\u1eadp trung v\u00e0o c\u00e1c li\u1ec7u ph\u00e1p \u0111\u01b0\u1eddng u\u1ed1ng gi\u00fap b\u1ec7nh nh\u00e2n ti\u1ec7n l\u1ee3i h\u01a1n so v\u1edbi thu\u1ed1c ti\u00eam truy\u1ec1n th\u1ed1ng.<\/p>\n<p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb<\/strong>: N\u0103m 2025, BioCryst tr\u1edf th\u00e0nh c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7u ti\u00ean s\u1eed d\u1ee5ng t\u1ed1i \u01b0u h\u00f3a th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng b\u1eb1ng AI, r\u00fat ng\u1eafn th\u1eddi gian ph\u00e1t tri\u1ec3n 30% trong khi v\u1eabn duy tr\u00ec c\u00e1c ti\u00eau chu\u1ea9n an to\u00e0n nghi\u00eam ng\u1eb7t.<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals (BCRX)?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu BCRX th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n cung c\u1ea5p c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft tr\u00ean NASDAQ. M\u1edf t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, nghi\u00ean c\u1ee9u c\u00f4ng ty, \u0111\u1eb7t l\u1ec7nh mua v\u1edbi gi\u00e1 gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a b\u1ea1n."},{"question":"BioCryst Pharmaceuticals c\u00f3 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng nh\u01b0 th\u1ebf n\u00e0o trong n\u0103m 2025?","answer":"C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o c\u1ed5 phi\u1ebfu BCRX c\u00f3 th\u1ec3 t\u0103ng h\u01a1n 100% trong n\u0103m 2025 nh\u1edd m\u1edf r\u1ed9ng doanh thu t\u1eeb thu\u1ed1c ORLADEYO v\u00e0 kh\u1ea3 n\u0103ng ph\u00ea duy\u1ec7t cho tr\u1ebb em."},{"question":"Nh\u1eefng r\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o BioCryst l\u00e0 g\u00ec?","answer":"R\u1ee7i ro bao g\u1ed3m kh\u00f4ng ch\u1eafc ch\u1eafn v\u1ec1 ph\u00ea duy\u1ec7t FDA, \u00e1p l\u1ef1c c\u1ea1nh tranh t\u1eeb c\u00e1c s\u1ea3n ph\u1ea9m kh\u00e1c, m\u1ea5t doanh thu ch\u00e2u \u00c2u, ph\u1ee5 thu\u1ed9c l\u1edbn v\u00e0o m\u1ed9t s\u1ea3n ph\u1ea9m duy nh\u1ea5t v\u00e0 kh\u1ea3 n\u0103ng th\u1ea5t b\u1ea1i trong c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng."},{"question":"Pocket Option c\u00f3 ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi kh\u00f4ng?","answer":"C\u00f3, Pocket Option r\u1ea5t ph\u00f9 h\u1ee3p cho ng\u01b0\u1eddi m\u1edbi v\u1edbi s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 t\u00e0i kho\u1ea3n demo \u0111\u1ec3 luy\u1ec7n t\u1eadp kh\u00f4ng r\u1ee7i ro."},{"question":"BioCryst Pharmaceuticals t\u1eadp trung v\u00e0o l\u0129nh v\u1ef1c n\u00e0o?","answer":"BioCryst t\u1eadp trung v\u00e0o \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh hi\u1ebfm, \u0111\u1eb7c bi\u1ec7t l\u00e0 ph\u00f9 m\u1ea1ch di truy\u1ec1n, h\u1ed9i ch\u1ee9ng Netherton v\u00e0 ph\u00f9 ho\u00e0ng \u0111i\u1ec3m do ti\u1ec3u \u0111\u01b0\u1eddng, v\u1edbi c\u00e1c li\u1ec7u ph\u00e1p \u0111\u01b0\u1eddng u\u1ed1ng ti\u1ec7n l\u1ee3i."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals (BCRX)?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu BCRX th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n cung c\u1ea5p c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft tr\u00ean NASDAQ. M\u1edf t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, nghi\u00ean c\u1ee9u c\u00f4ng ty, \u0111\u1eb7t l\u1ec7nh mua v\u1edbi gi\u00e1 gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a b\u1ea1n."},{"question":"BioCryst Pharmaceuticals c\u00f3 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng nh\u01b0 th\u1ebf n\u00e0o trong n\u0103m 2025?","answer":"C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o c\u1ed5 phi\u1ebfu BCRX c\u00f3 th\u1ec3 t\u0103ng h\u01a1n 100% trong n\u0103m 2025 nh\u1edd m\u1edf r\u1ed9ng doanh thu t\u1eeb thu\u1ed1c ORLADEYO v\u00e0 kh\u1ea3 n\u0103ng ph\u00ea duy\u1ec7t cho tr\u1ebb em."},{"question":"Nh\u1eefng r\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o BioCryst l\u00e0 g\u00ec?","answer":"R\u1ee7i ro bao g\u1ed3m kh\u00f4ng ch\u1eafc ch\u1eafn v\u1ec1 ph\u00ea duy\u1ec7t FDA, \u00e1p l\u1ef1c c\u1ea1nh tranh t\u1eeb c\u00e1c s\u1ea3n ph\u1ea9m kh\u00e1c, m\u1ea5t doanh thu ch\u00e2u \u00c2u, ph\u1ee5 thu\u1ed9c l\u1edbn v\u00e0o m\u1ed9t s\u1ea3n ph\u1ea9m duy nh\u1ea5t v\u00e0 kh\u1ea3 n\u0103ng th\u1ea5t b\u1ea1i trong c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng."},{"question":"Pocket Option c\u00f3 ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi kh\u00f4ng?","answer":"C\u00f3, Pocket Option r\u1ea5t ph\u00f9 h\u1ee3p cho ng\u01b0\u1eddi m\u1edbi v\u1edbi s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 t\u00e0i kho\u1ea3n demo \u0111\u1ec3 luy\u1ec7n t\u1eadp kh\u00f4ng r\u1ee7i ro."},{"question":"BioCryst Pharmaceuticals t\u1eadp trung v\u00e0o l\u0129nh v\u1ef1c n\u00e0o?","answer":"BioCryst t\u1eadp trung v\u00e0o \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh hi\u1ebfm, \u0111\u1eb7c bi\u1ec7t l\u00e0 ph\u00f9 m\u1ea1ch di truy\u1ec1n, h\u1ed9i ch\u1ee9ng Netherton v\u00e0 ph\u00f9 ho\u00e0ng \u0111i\u1ec3m do ti\u1ec3u \u0111\u01b0\u1eddng, v\u1edbi c\u00e1c li\u1ec7u ph\u00e1p \u0111\u01b0\u1eddng u\u1ed1ng ti\u1ec7n l\u1ee3i."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T18:21:07+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX)\",\"datePublished\":\"2025-08-20T18:21:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"datePublished\":\"2025-08-20T18:21:07+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T18:21:07+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX)","datePublished":"2025-08-20T18:21:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","datePublished":"2025-08-20T18:21:07+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BioCryst Pharmaceuticals, Inc. (BCRX)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":342491,"slug":"how-to-buy-biocryst-pharmaceuticals","post_title":"Como comprar a\u00e7\u00f5es da BioCryst Pharmaceuticals, Inc. (BCRX) - Investimento em a\u00e7\u00f5es da BioCryst Pharmaceuticals, Inc. (BCRX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-biocryst-pharmaceuticals\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/342493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=342493"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/342493\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334063"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=342493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=342493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=342493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}